On June 20th, Ali Health announced that it has signed a strategic cooperation agreement with Merck, a pharmaceutical and pharmaceutical company. The two sides announced that they will cooperate in drug traceability and Internet health services, and actively explore medical e-commerce and artificial intelligence.
It is reported that the first step of the cooperation between the two sides will trace the landing drug, Merck's drugs in the diabetes, thyroid and cardiovascular fields settled in the Ali health code platform. After entering the hospital, the patient purchases Merck related drugs, scans the trace code on the medicine package through mobile phone Taobao, Alipay, Ali Health and other APP, and can obtain the drug verification, drug instruction information, disease knowledge, expert doctor course, etc. in the result page. You can also consult a licensed pharmacist for free medication.
In addition, in the future, patients with chronic diseases can receive medication reminders from various channels such as APP and smart hardware. In addition to being assured of the code, the two parties will continue to explore the medical services (DTP model) that rely on the medical e-commerce system to reach patients directly, and the application of artificial intelligence in the health field.
At present, Ali Health has carried out innovative cooperation in various fields with GSK, Bayer, Sanofi, Merck, AstraZeneca, Pfizer and many other multinational pharmaceutical companies.
Cosmetics Ingredients
SINOCHEM PHARMACEUTICAL CO., LTD , https://www.sinochemnutrition.com